Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001696841 | SCV000535907 | likely benign | not provided | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000473372 | SCV000563540 | likely benign | Primary dilated cardiomyopathy | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022519 | SCV002749141 | likely benign | not specified | 2022-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001696841 | SCV004126530 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | NEBL: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV001696841 | SCV001929053 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001696841 | SCV001955061 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001696841 | SCV001969861 | likely benign | not provided | no assertion criteria provided | clinical testing |